Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia.

Andreeff M, Kelly KR, Yee K, Assouline S, Strair R, Popplewell L, Bowen D, Martinelli G, Drummond MW, Vyas P, Kirschbaum M, Iyer SP, Ruvolo V, González GM, Huang X, Chen G, Graves B, Blotner S, Bridge P, Jukofsky L, Middleton S, Reckner M, Rueger R, Zhi J, Nichols G, Kojima K.

Clin Cancer Res. 2016 Feb 15;22(4):868-76. doi: 10.1158/1078-0432.CCR-15-0481. Epub 2015 Oct 12.

2.

Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial.

Pardanani A, Harrison C, Cortes JE, Cervantes F, Mesa RA, Milligan D, Masszi T, Mishchenko E, Jourdan E, Vannucchi AM, Drummond MW, Jurgutis M, Kuliczkowski K, Gheorghita E, Passamonti F, Neumann F, Patki A, Gao G, Tefferi A.

JAMA Oncol. 2015 Aug;1(5):643-51. doi: 10.1001/jamaoncol.2015.1590.

PMID:
26181658
3.

A multi-centre phase 2 study of azacitidine in chronic myelomonocytic leukaemia.

Drummond MW, Pocock C, Boissinot M, Mills J, Brown J, Cauchy P, Cross NC, Hartley S, Kell J, Szubert A, Cockerill PN, Bowen DT.

Leukemia. 2014 Jul;28(7):1570-2. doi: 10.1038/leu.2014.85. Epub 2014 Feb 26. No abstract available.

PMID:
24569776
4.

Reversible nicorandil induced perianal ulceration in acute myeloid leukemia.

Ahmad FA, Drummond MW.

Leuk Lymphoma. 2012 Feb;53(2):334-5. doi: 10.3109/10428194.2011.610016. Epub 2011 Sep 23. No abstract available.

PMID:
21823834
5.

Primary lymphedema and acute leukemia--is there a link?

Todd M, Welsh J, Drummond MW.

Lymphology. 2010 Mar;43(1):42-4.

PMID:
20552819
6.

Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia.

Milojkovic D, Nicholson E, Apperley JF, Holyoake TL, Shepherd P, Drummond MW, Szydlo R, Bua M, Foroni L, Reid A, Khorashad JS, de Lavallade H, Rezvani K, Paliompeis C, Goldman JM, Marin D.

Haematologica. 2010 Feb;95(2):224-31. doi: 10.3324/haematol.2009.012781. Epub 2009 Oct 14.

7.

Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib.

Foo J, Drummond MW, Clarkson B, Holyoake T, Michor F.

PLoS Comput Biol. 2009 Sep;5(9):e1000503. doi: 10.1371/journal.pcbi.1000503. Epub 2009 Sep 11.

8.

Identification of high oxygen affinity hemoglobin variants in the investigation of patients with erythrocytosis.

Percy MJ, Butt NN, Crotty GM, Drummond MW, Harrison C, Jones GL, Turner M, Wallis J, McMullin MF.

Haematologica. 2009 Sep;94(9):1321-2. doi: 10.3324/haematol.2009.008037. No abstract available.

9.

Furtive bleeding.

Murray E, Nunn KP, Magill LJ, Drummond MW.

Am J Med. 2009 Aug;122(8):729-31. doi: 10.1016/j.amjmed.2009.04.008. No abstract available.

PMID:
19635273
10.

A pilot study of continuous imatinib vs pulsed imatinib with or without G-CSF in CML patients who have achieved a complete cytogenetic response.

Drummond MW, Heaney N, Kaeda J, Nicolini FE, Clark RE, Wilson G, Shepherd P, Tighe J, McLintock L, Hughes T, Holyoake TL.

Leukemia. 2009 Jun;23(6):1199-201. doi: 10.1038/leu.2009.43. Epub 2009 Mar 5. No abstract available.

PMID:
19262595
11.

Pseudotumour cerebri as a manageable side effect of prolonged all-trans retinoic acid therapy in an adult patient with acute promyelocytic leukaemia.

Gallipoli P, Drummond MW.

Eur J Haematol. 2009 Mar;82(3):242-3. doi: 10.1111/j.1600-0609.2008.01185.x. Epub 2008 Nov 10. No abstract available. Erratum in: Eur J Haematol. 2009 May;82(5):411. Drummond, M W [added].

PMID:
19018859
12.

Isolated central nervous system lymphoid blast crisis in chronic myeloid leukaemia in major molecular remission.

Barlow A, Robertson M, Doig A, Stewart W, Drummond MW.

Br J Haematol. 2008 Jul;142(3):327. doi: 10.1111/j.1365-2141.2008.07136.x. Epub 2008 May 15. No abstract available.

PMID:
18492112
13.

Concise review: Telomere biology in normal and leukemic hematopoietic stem cells.

Drummond MW, Balabanov S, Holyoake TL, Brummendorf TH.

Stem Cells. 2007 Aug;25(8):1853-61. Epub 2007 May 17. Review.

14.

Dysregulated expression of the major telomerase components in leukaemic stem cells.

Drummond MW, Hoare SF, Monaghan A, Graham SM, Alcorn MJ, Keith WN, Holyoake TL.

Leukemia. 2005 Mar;19(3):381-9.

PMID:
15674365
15.

Fluorescence in situ hybridization for BCR-ABL.

Drummond MW, Allan EK, Pearce A, Holyoake TL.

Methods Mol Med. 2004;97:103-16. No abstract available.

PMID:
15064488
16.

Mobilization of Ph chromosome-negative peripheral blood stem cells in chronic myeloid leukaemia patients with imatinib mesylate-induced complete cytogenetic remission.

Drummond MW, Marin D, Clark RE, Byrne JL, Holyoake TL, Lennard A; United Kingdom Chronic Myeloid Leukaemia (UK CML) Working Party.

Br J Haematol. 2003 Nov;123(3):479-83.

PMID:
14617010
18.

A spectrum of skin reactions caused by the tyrosine kinase inhibitor imatinib mesylate (STI 571, Glivec).

Drummond A, Micallef-Eynaud P, Douglas WS, Hay I, Holyoake TL, Drummond MW.

Br J Haematol. 2003 Mar;120(5):911-3. No abstract available.

PMID:
12614232
19.

Imatinib mesylate-induced molecular remission of Philadelphia chromosome-positive myelodysplastic syndrome.

Drummond MW, Lush CJ, Vickers MA, Reid FM, Kaeda J, Holyoake TL.

Leukemia. 2003 Feb;17(2):463-5. No abstract available.

PMID:
12592349
20.

BCR-ABL FISH monitoring of CML: a survey of current UK practice.

Drummond MW, Hendry LM, Maher E, Holyoake TL.

Br J Haematol. 2002 Oct;119(1):272-3. No abstract available.

PMID:
12358936
21.

Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia.

Holyoake TL, Jiang X, Drummond MW, Eaves AC, Eaves CJ.

Leukemia. 2002 Apr;16(4):549-58. Review.

22.

Tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia: so far so good?

Drummond MW, Holyoake TL.

Blood Rev. 2001 Jun;15(2):85-95. Review.

PMID:
11409908
23.

Management of a Jehovah's witness with thrombotic thrombocytopaenic purpura/haemolytic uraemic syndrome.

Drummond MW, Green R, Callaghan T, Watson D, Simpson K.

J Clin Apher. 2000;15(4):266-7. No abstract available.

PMID:
11124696
24.

Arterial thrombosis, GM-CSF, and the lupus anticoagulant.

Drummond MW, Spearing R.

Am J Hematol. 2000 Jun;64(2):143. No abstract available.

PMID:
10814998
25.

Supplemental Content

Loading ...
Support Center